Conservative management (active surveillance or watchful waiting) for low-risk prostate cancer is an increasingly used alternative to definitive radiation therapy or radical prostatectomy.
1,2 Given the underrepresentation of black patients in clinical trials and concern about underlying aggressive disease,
3,4 expert panels advise caution when applying conservative management to black patients.
1 Therefore, we examined recent trends in the use of active surveillance or watchful waiting in black men, as compared with nonblack men, with low-risk prostate cancer in the United States.